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OBJECTIVE: This retrospective study aimed to investigate the relationship between admission levels of serum c-
glutamyltransferase and poor myocardial perfusion after primary percutaneous coronary intervention in patients
with acute myocardial infarction.
INTRODUCTION: Reperfusion injury caused by free radical release and increased oxidative stress is responsible for
the pathophysiology of the no-reflow phenomenon in patients with acute myocardial infarction undergoing
primary percutaneous coronary intervention. Serum c-glutamyltransferase is an established marker of increased
oxidative stress.
METHODS: The study population consisted of 80 patients (64 men and 16 women, mean age=67.5¡6.6 years) with
thrombolysis in myocardial infarction 0/1 flow pre-procedurally. The patients were divided into two groups
according to thrombolysis in myocardial perfusion grades that were assessed immediately following primary
percutaneous coronary intervention. The two groups (group 1 and group 2) each consisted of 40 patients with
thrombolysis in myocardial perfusion grades 0-1 and thrombolysis in myocardial perfusion grades 2-3, respectively.
RESULTS: Admission pain to balloon time, c-glutamyltransferase and creatine kinase-MB isoenzyme levels of group
1 patients were significantly higher than those of group 2 patients. Pain to balloon time, c-glutamyltransferase,
peak creatine kinase-MB isoenzyme, low left ventricular ejection fraction and poor pre-procedural thrombolysis in
myocardial infarction grade were significantly associated with poor myocardial perfusion by univariate analysis.
However, only pain to balloon time and c-glutamyltransferase levels showed a significant independent association
with poor myocardial perfusion by backward logistic regression analysis. Adjusted odds ratios were calculated as
4.92 for pain to balloon time and 1.13 for c-glutamyltransferase.
CONCLUSION: High admission c-glutamyltransferase levels are associated with poor myocardial perfusion in
patients with acute myocardial infarction undergoing primary percutaneous coronary intervention, particularly in
patients with prolonged pain to balloon time.
KEYWORDS: Myocardial infarction; No-reflow phenomenon; Gamma-glutamyltransferase.
Yuksel UC, Celik T, Celik M, Bugan B, Iyisoy A, Yaman H. High admission levels of c-glutamyltransferase predict poor myocardial perfusion after
primary percutaneous intervention. Clinics. 2011;66(10):1729-1734.
Received for publication on March 23, 2011; First review completed on April 22, 2011; Accepted for publication on June 23, 2011
E-mail: benturgay@yahoo.com
Tel.: 90 312 3044268
INTRODUCTION
The objective of primary percutaneous coronary interven-
tion (pPCI) is to restore normal blood flow in the infarct-
related artery (IRA). Previous studies have shown that
preservation of the microcirculation is critical for a positive
clinical outcome.1 It is well-known that achieving
Thrombolysis in Myocardial Infarction (TIMI) grade 3 flow
is insufficient to ensure myocardial salvage.1,2 In one-third of
patients undergoing pPCI for acute myocardial infarction,
echo-contrast ‘no-reflow’ is observed after reperfusion ther-
apy, despite TIMI grade 3 flow. This ‘no-reflow’ phenomenon
is associated with a higher incidence of congestive heart
failure and left ventricular dysfunction.3 The TIMImyocardial
perfusion grade (TMPG) was designed and validated to
further risk-stratify patients in whom succsessful epicardial
reperfusion was achieved.2 TMPG is a multivariate predictor
of 30-day mortality, and is independent of age, gender,
anterior MI location, admission pulse rate, corrected TIMI
frame count, or TIMI flow grade.2 Previous clinical studies
have clearly demonstrated that no-reflow predicts short- and
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long-term adverse clinical outcomes in patients presenting
with acute myocardial infarction (AMI).4
Gamma-glutamyltransferase (GGT), an enzyme that is
normally found in the serum as well as in the plasma
membrane of virtually all cells except erythrocytes, cata-
lyzes the first step in the degradation of extracellular
glutathione (GSH). This degradation allows for precursor
assimilation and reutilization of amino acids for synthesis of
intracellular GSH, the primary thiol antioxidant in mamma-
lian cells.5 Serum GGT level is widely used as a diagnostic
test for hepatobiliary diseases and alcohol abuse.6 Several
clinical studies have shown that elevated serum GGT is
associated with all-cause mortality and increased risk of
AMI.7 Additionally, degradation of GSH may play a pro-
oxidant role under certain conditions. Low density lipopro-
tein (LDL) oxidation through GSH/GGT-dependent iron
reduction has been suggested as an important mechanism in
the pathogenesis of atherosclerosis.8 Furthermore, GGT
activity has been observed in atherosclerotic coronary
plaques.9 Reperfusion injury due to free radical release
and increased oxidative stress has been suggested as a
possible mechanism in the pathophysiology of the no-
reflow phenomenon.10 Therefore, we aimed to examine the
possible relationship between admission levels of GGT and
myocardial perfusion grades after pPCI in patients present-
ing with AMI.
MATERIALS AND METHODS
Patients
The study population consisted of 40 patients with poor
myocardial perfusion (TMPG 0-1) after pPCI and 40 age and
sex-matched patients with better perfusion grades (TMPG 2-
3) after the procedure (total 80 patients, 64 men and 16
women, mean age= 67.5¡6.6 years). The retrospective
selection included 265 acute ST-segment elevation myocar-
dial infarction (STEMI) patients who were treated by pPCI
from January 2003 to December 2007 at our institution.
The diagnosis of AMI was established using ACC/AHA
criteria.11 All patients presented TIMI 0/1 flow prior to
intervention. The study population was divided into two
groups according to TMPG assessed immediately after
pPCI. No-reflow was defined as poor TMPG scores (TMPG
0-1) in the distal vasculature without apparent proximal
coronary artery obstruction after intervention. Each group
(group 1 and group 2) consisted of 40 patients with TMPG 0-
1 and TMPG 2-3, respectively. Part of the data included in
this study was previously published elsewhere.12
Patients with liver dysfunction and a history of chronic
alcohol consumption, culprit lesion in the left main coronary
artery, left main stenosis .50%, previous coronary artery
bypass surgery, hemodialysis therapy, cardiogenic shock,
pain to balloon time .12 hours, history of acute infection
within the previous 10 days, presence of any chronic
inflammatory-autoimmune disease, and any known malig-
nancy were excluded from the study.
Coronary Intervention, Analysis of Collateral
Circulation and TIMI Myocardial Perfusion Grade
Coronary angiography (Siemens HICOR T.O.P Image
System, Forcheim, Germany) was performed in multiple
orthogonal projections using Judkins’ technique. Coronary
angiographic data were quantitatively analyzed. A stenosis
of greater than 70% diameter in coronary arteries 1, 2, and 3
was defined as a one, two, or three-vessel disease,
respectively. Collateral vessels were assessed according to
the Rentrop classification.13 Routine stenting following
balloon angioplasty was systematically attempted with
standard techniques, including high-pressure balloon infla-
tion (.14 atm) to expand deployed stents. A successful
primary PCI procedure was defined as establishing a TIMI
grade 3 flow in the artery responsible for AMI with a
residual stenosis ,20%.14 TMPG was graded densitome-
trically according to visual assessment of relative contrast
opacification in the myocardial territory subtended by the
infarct vessel in relation to epicardial density.1
Echocardiography
Transthoracic echocardiography was performed using an
ESAOTE 2.5 MHz probe (ESAOTE, Genova, Italy) at the left
lateral decubitis position before pPCI. Wall motion of 16
myocardial segments was interpreted according to the
criteria of the American Society of Echocardiography.15
Blood Chemistry
Venous blood samples were obtained on admission to the
emergency room and analyzed for blood urea nitrogen,
GGT, alanine aminotransferase (ALT), aspartate amino-
transferase (AST) and creatine kinase-MB isoenzyme
(CKMB) levels. The next day, fasting plasma samples were
obtained to measure: fasting plasma glucose (FPG), total
serum cholesterol (TC), triglyceride (TG), high-density
lipoprotein (HDL), and low-density lipoprotein (LDL)
cholesterol. Total serum cholesterol, TG, HDL, glucose,
and GGT levels were measured via spectrophotometric
technique on an Olympus AU-2700 autoanalyzer using
commercial kits (Olympus, Hamburg, Germany). LDL
cholesterol levels were calculated by the Friedwald formula.
Statistical Analysis
The One Sample Kolmogorov-Smirnov and Levene tests
were used to determine the distribution characteristics of
variables and variance homogeneity. Results are expressed
as mean ¡ SD, median (interquartile range) and percen-
tages. The differences between groups were tested by chi-
square, independent samples t-test and Mann-Whitney U
tests. Differences were considered significant at p,0.05. We
investigated the effects of different variables on myocardial
perfusion grade by calculating the odds ratios in a
univariate analysis for all variables. Variables displaying
an unadjusted p-value ,0.15 in logistic regression analysis
were identified as potential risk markers and included in the
multivariate regression analysis. We reduced the model
using backward elimination, and we eliminated potential
risk markers through likelihood ratio tests. Statistical
analyses were performed using the SPSS 15.0 Statistical
Package Program for Windows (SPSS Inc., Chicago, IL,
USA).
RESULTS
This retrospective study included 80 patients who
presented with acute ST-segment elevation myocardial
infarction (64 men and 16 women, mean age= 67.5¡6.6
years). All patients presented TIMI 0/1 flow pre-procedu-
rally. Post-procedural TMPGs were analyzed by two
different interventional cardiologists who were blinded
to the patients’ clinical data. Intra- and interobserver
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variability for TMPGs 0-1 were 7.5% and 10.5%, respec-
tively. Although intra- and interobserver variability for
TMPG 2 were 1.9% and 2.7%, respectively, both the intra-
and interobserver variability for TMPG 3 were 0%. In cases
of disagreement between the observers, the cases were re-
evaluated by both investigators and grouped according to
the common final decision. Patients with TMPG 0-1 and 2-3
formed Group 1 (n= 40, 30 men, mean age = 68.8¡5.3 years)
and Group 2 (n = 40, 34 men, mean age= 66.2¡7.5 years),
respectively. Comparison between baseline demographical,
clinical, and biochemical characteristics of patients with no-
reflow and controls showed no statistically significant
differences, except for peak CKMB and GGT levels, as
shown in Tables 1 and 2 (for CKMB: 172.4¡45.1 U/l vs.
144.5¡37.8 U/l, p= 0.003 and for GGT: 64.32¡16.43 U/L
vs. 41.07¡10.18 U/L, p,0.001; Figure 1). We performed an
ROC curve analysis to define the optimal cut-off value of
admission-GGT to predict no-reflow. A cut-off value of
50 U/L GGT predicted no-reflow with a sensitivity and
specificity of 82.5% and 80%, respectively (AUC=0.873; 95%
CI = 0.791-0.955; p,0.001, Figure 2).
The two groups presented with similar angiographic,
echocardiographic, and electrocardiographic characteristics.
However, pain to balloon time and admission TIMI flow
grades (TIMI flow 0-1) were significantly different between
the two groups (Table 3). Direct stenting was performed in
three patients from Group 1 and 2 patients from Group 2.
Drug-eluting stents were used in two patients from each
group. In Group 1, pain to balloon time was longer
(6.07¡0.72 h vs. 4.63¡1.16 h, p,0.001) and the percentage
of low admission TIMI flow grades was higher than for
patients in Group 2 (95% vs. 80%, p= 0.03).
The effects of different variables on myocardial perfusion
were analyzed using univariate and multivariate logistic
regression analyses. Data for the two groups was combined,
and all the variables were analyzed via univariate analysis
for predictors of poor myocardial perfusion. As shown in
Table 3, pain to balloon time, GGT levels, peak CKMB
levels, low LVEF, poor TIMI grade, wall motion score, and
older age displayed a significant relationship with poor
myocardial perfusion in the univariate analysis. When
multivariate analyses were performed with eight variables
in backward logistic regression analysis, only pain to
balloon time and GGT levels continued to display a
statistically significant independent association with poor
myocardial perfusion in the model. Adjusted odds ratios
were calculated as 4.92 for pain to balloon time (p= 0.009;
CI = 1.50-16.13) and 1.13 for GGT (p,0.001; CI = 1.05-1.21), as
shown in Table 4.
DISCUSSION
Our study revealed that in patients with AMI undergoing
pPCI, high admission GGT levels are associated with lower
myocardial perfusion grades after intervention.
The no-reflow phenomenon is primarily attributed to the
disturbed microvascular integrity that occurs due to free
radical release, microvascular constriction and obstruction,
platelet microembolism, thrombosis and neutrophil aggre-
gation and plugging.16-18
Table 1 - Baseline demographic and clinical characteristics of the study patients.
Group 1 (n= 40) Group 2 (n= 40) p-value
Age (years) 68.8¡5.3 66.2¡7.5 0.08
Sex (M), n (%) 30 (75) 34 (85) 0.26
Age .70 years, n (%) 14 (35) 8 (20) 0.13
BMI (kg/m2) 25.9¡2.0 25.5¡1.7 0.42
Hypercholesterolemia, n (%) 14 (35) 12 (30) 0.63
Diabetes mellitus, n (%) 17 (42.5) 15 (37.5) 0.64
Family history, n (%) 10 (25) 6 (15) 0.26
Hypertension, n (%) 26 (65) 21 (52.5) 0.25
Smoking, n (%) 19 (47.5) 26 (65) 0.12
Preinfarction angina, n (%) 15 (37.5) 17 (42.5) 0.64
Previous MI, n (%) 5 (12.5) 7 (17.5) 0.53
Admission HR (bpm) 91¡12 86¡13 0.15
Killip Class Class I, n (%) 36 (90) 37 (92.5) 0.69
Class II-III, n (%) 4 (10) 3 (7.5)
Preprocedural medications Aspirin, n (%) 15 (37.5) 21 (52.5) 0.17
Nitrate, n (%) 18 (45) 15 (37.5) 0.49
BAB, n (%) 12 (30) 16 (40) 0.35
ACE-I, n (%) 15 (37.5) 19 (47.5) 0.36
Statin, n (%) 15 (37.5) 22 (55) 0.11
I, Body mass index; MI, myocardial infarction; HR, heart rate; BAB, beta adrenergic blocker; ACE-I, angiotensin converting enzyme inhibitor.
Table 2 - Baseline biochemical characteristics of the study
patients.
Group 1 (n = 40) Group 2 (n= 40) p-value
GGT (U/L) 41.07¡10.18 64.32¡16.43 ,0.001
Peak CKMB (U/l) 172.4¡45.1 144.5¡37.8 0.003
AST (U/L) 50.90¡9.68 52.81¡12.27 0.44
ALT (U/L) 34.27¡8.55 37.10¡9.09 0.15
Total cholesterol
(mg/dl)
253.75 (227-290) 255.00 (236-300) 0.37
Triglyceride
(mg/dl)
165.00 (132-244) 153.75 (144-254) 0.85
LDL cholesterol
(mg/dl)
172.87 (142-215) 166.10 (142-224) 0.55
HDL cholesterol
(mg/dl)
40.50 (37-48) 39.25 (27-50) 0.57
GT, Gamma-glutamyltransferase; CKMB, Creatine kinase-MB isoenzyme;
AST, Alanine aminotransferase; ALT, Aspartate aminotransferase; LDL,
Low density lipoprotein; HDL, High density lipoprotein.
Results are expressed as mean¡SD or median (interquartile range).
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Reperfusion of the ischemic myocardium in AMI results
in oxidative stress caused by the release of quantities of
reactive oxygen species (ROS) that exceed the neutralizing
potential of the cells’ anti-oxidative defense mechanisms.19
Oxidative cellular damage induced by high levels of
reactive oxygen species is considered a primary cause of
lethal myocardial reperfusion injury. The generation of
reactive oxygen species during reperfusion is a complex
process involving cardiomyocytes, endothelial cells, and
activated neutrophils. Re-energization of the electron trans-
port chain in the mitochondria of cardiomyocytes leads to
the formation of ubiquinone and oxygen-derived radi-
cals.20,21 After breaking down ATP, post-ischemic cardio-
myocytes release large amounts of adenosine and inosine,
which are further degraded by xanthine oxidase in
endothelial cells, constituting another important source of
ROS.21
Serum GGT level has been suggested as an independent
cardiovascular risk factor.22 It is also a predictor of all-cause
and coronary heart disease-related mortality, independent
of alcohol intake or liver disease.7 GGT expression is
increased by oxidants, and GGT activity serves as a marker
for oxidative stress in rat lung epithelial cells.23 Increased
serum GGT activity can be used as a marker for increased
oxidative stress in humans.24 Increased GGT activity is also
present in atherosclerotic coronary plaques.8
Oxidative and inflammatory events are closely related in the
pathophysiology of acute coronary syndrome (ACS).25 Serum
GGT activity has been suggested as an independent predictor
of major adverse cardiovascular events in patients with ACS
during coronary care unit stay and after hospitalization.26
In the microvasculature of the heart, post-ischemic
reperfusion results in endothelial cell swelling and luminal
membrane blebbing, both of which may contribute to the
no-reflow phenomenon.27 Ischemia results in impaired
antioxidant defense, and subsequent reperfusion results in
an increased concentration of reactive oxygen species.19 In
the current study, we demonstrated that increased pre-
procedural GGT levels display a statistically significant
independent association with poor myocardial perfusion.
From this perspective, we suggest that increased pre-
procedural oxidative stress represented by GGT levels
may be an important factor contributing to microvascular
damage in patients with AMI. Higher levels of GGT in
patients with poor TMPG may be the result of increased
microvascular injury and increased oxidative stress. High
Figure 1 - Comparison of Gamma-glutamyltransferase levels
between study groups. (TMPG: TIMI myocardial perfusion
grade).
Figure 2 - ROC curve of Gamma-glutamyltransferase for predict-
ing no-reflow. (AUC: area under curve).
Table 3 - Angiographic, echocardiographic, and
electrocardiographic characteristics of the patients.
Group 1
(n= 40)
Group 2
(n = 40) p-value
Pain to balloon time (h) 6.07¡0.72 4.63¡1.16 ,0.001
Tirofiban use, n (%) 13 (32.5) 11 (27.5) 0.62
Preprocedural TIMI 0/1, n (%) 38 (95) 32 (80) 0.03
LVEF (,35%), n (%) 16 (40) 12 (30) 0.34
Multivessel disease, n (%) 13 (32.5) 10 (25) 0.45
Infarct- related artery LAD, n (%) 14 (35) 16 (40.0) 0.85
RCA, n (%) 20 (50) 19 (47.5)
CFX, n (%) 6 (15) 5 (12.5)
Reference diameter (mm) 3.03¡0.26 3.12¡0.23 0.20
Lesion length (mm) 17.05¡2.51 16.90¡2.68 0.79
Final balloon pressure (Atm) 15.25¡2.06 15.82¡1.78 0.18
Collateral score 0.87¡0.56 0.90¡0.67 0.85
Number of Q waves 2.92¡1.24 2.40¡ 1.62 0.11
LVEF (,35%), n (%) 16 (40) 12 (30) 0.34
WMS 12.92¡2.65 12.15¡1.62 0.15
LAD, Left anterior descending coronary artery; RCA, Right coronary
artery; CFX, Circumflex coronary artery; MLD, Minimal lumen diameter;
LVEF, Left ventricular ejection fraction; TIMI, Thrombolysis in myocardial
infarction; WMS, Wall motion score.
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GGT activity can also represent a compensatory response
against the microvascular injury caused by free radicals. It is
also reasonable to expect increased GGT activity due to
delayed pain-balloon time and subsequent increased myo-
cardial injury. On the other hand, peak CKMB levels, which
are a specific marker of myocardial injury, have been found
to be independent of TMPG. Therefore, the significant
association between TMPG and increased GGT activity as a
non-specific marker for myocardial injury highlights the
importance of oxidative stress in reperfusion injury, poor
TMPG and ischemic injury.
The role of admission GGT levels in the prediction of poor
myocardial perfusion grades after pPCI in patients with AMI
has not been extensively studied.28 The dynamic nature of
acute coronary syndromes is usually associated with sponta-
neous ischemia-reperfusion injury in the infarct-related
artery.29 Therefore, we considered the fact that poor
myocardial perfusion after pPCI is not only related to
procedural factors and clinical characteristics of the patients
but may also be related to reperfusion injury and oxidative
stress occurring before coronary intervention. GGT can be
used as a marker of poor post-procedural flow. However, the
current data is not sufficient to suggest GGT as a causal agent.
The major limitations of this study are small sample size
and retrospective design. Additionally, self-reported alcohol
consumption may not be reliable. This study did not include
a control group to compare the GGT levels of the AMI
patients with healthy subjects. Lastly, we did not analyze
other important plasma markers of oxidative stress, such as
oxidized LDL and plasma and/or intracellular GSH levels.
In conclusion, high admission GGT levels are associated
with poor myocardial perfusion after pPCI in patients with
AMI. High GGT levels and door to balloon time relate to
the degree of reperfusion after pPCI. An animal model
comparing reperfusion injury in animals with higher and
lower GGT levels would provide further evidence to
support our findings. Additional large-scale randomized
studies are needed to clarify the clinical utility of admission
GGT levels in the prediction of poor myocardial perfusion.
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